Elanco Animal Health (ELAN) Receivables (2017 - 2026)

Elanco Animal Health has disclosed Receivables across 10 years of filings, most recently posting $1.2 billion for Q2 2026.

• In Q2 2026, Receivables rose 4.44% year-over-year to $1.2 billion; the TTM figure through Jun 2026 stood at $1.2 billion (up 4.44% YoY), while the FY2025 annual figure was $940.0 million, up 6.09% from the prior year.
• Receivables came in at $1.2 billion for Q2 2026 at Elanco Animal Health, roughly flat from $1.2 billion in the prior quarter.
• In the past five years, Receivables ranged from a high of $1.3 billion in Q1 2023 to a low of $886.0 million in Q4 2024.
• Average Receivables over 5 years is $1.1 billion, with a median of $1.1 billion recorded in 2024.
• Year-over-year, Receivables grew 10.41% in 2023 and retreated 20.35% in 2024.
• Over 5 years, Receivables stood at $1.0 billion in 2022, then rose by 0.8% to $1.0 billion in 2023, then decreased by 12.28% to $886.0 million in 2024, then increased by 6.09% to $940.0 million in 2025, then advanced by 22.55% to $1.2 billion in 2026.
• Per Business Quant data, the three most recent Receivables figures were $1.2 billion in Q2 2026, $1.2 billion in Q1 2026, and $940.0 million in Q4 2025.